We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

152 hedge funds and large institutions have $493M invested in Rigel Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 42 increasing their positions, 54 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 23

2% more funds holding

Funds holding: 149 → 152 (+3)

2% more call options, than puts

Call options by funds: $2.2M | Put options by funds: $2.16M

1% more capital invested

Capital invested by funds: $489M → $493M (+$3.48M)

0.2% more ownership

Funds ownership: 8.28% → 8.48% (+0.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

22% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 54

Holders
152
Holders Change
+3
Holders Change %
+2.01%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
42
Reduced
54
Closed
23
Calls
$2.2M
Puts
$2.16M
Net Calls
+$43K
Net Calls Change
-$318K

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$19.2M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.2M
3
State Street
State Street
Massachusetts
+$12.5M
4
Millennium Management
Millennium Management
New York
+$10.5M
5
N
Nuveen
North Carolina
+$10.1M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$19.8M
2
Morgan Stanley
Morgan Stanley
New York
-$15.2M
3
Citadel Advisors
Citadel Advisors
Florida
-$12.1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$7.4M
5
Goldman Sachs
Goldman Sachs
New York
-$5.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$3.97M +$4.6M +116,090 New
Citigroup
27
Citigroup
New York
$2.65M +$2.2M +55,449 +251%
Wells Fargo
28
Wells Fargo
California
$2.44M +$1.19M +29,988 +73%
PAI
29
Palo Alto Investors
California
$2.23M -$1.37M -34,576 -35%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$2.14M +$2.12M +53,637 +602%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.12M -$201K -5,080 -8%
CM
32
CM Management
Florida
$1.71M +$396K +10,000 +25%
Charles Schwab
33
Charles Schwab
California
$1.47M +$54.6K +1,378 +3%
Barclays
34
Barclays
United Kingdom
$1.45M +$1.07M +27,003 +175%
WMSA
35
Weiss Multi-Strategy Advisers
New York
$1.32M -$221K -5,576 -13%
Swiss National Bank
36
Swiss National Bank
Switzerland
$1.31M – – –
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.18M -$126K -3,186 -8%
AG
38
Artal Group
Luxembourg
$1.1M – – –
UBS Group
39
UBS Group
Switzerland
$1.08M +$1.25M +31,475 New
UBS AM
40
UBS AM
Illinois
$1.04M -$9.62K -243 -0.8%
Los Angeles Capital Management
41
Los Angeles Capital Management
California
$983K -$2.14M -53,992 -65%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$959K +$295K +7,449 +36%
DCM
43
DAFNA Capital Management
California
$942K +$1.09M +27,550 New
Russell Investments Group
44
Russell Investments Group
United Kingdom
$879K -$1.36M -34,245 -57%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$876K -$6.73K -170 -0.7%
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$818K -$343K -8,665 -26%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$782K -$9.11K -230 -1%
PPA
48
Parametric Portfolio Associates
Washington
$778K +$462K +11,658 +105%
Renaissance Technologies
49
Renaissance Technologies
New York
$754K -$7.4M -186,811 -89%
Bank of America
50
Bank of America
North Carolina
$754K +$768K +19,395 +736%
1
2
3 4 5

RIGL Hedge Fund Activity: Q1 2021 in Review

152 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2021, worth a combined $493M — up 0.71% from $489M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RIGL positions and 23 closed out — a net gain of 5 holders — while 42 added to existing stakes and 54 trimmed.

The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $19.2M. The largest seller was Wellington Management Group, cutting an estimated $19.8M.

  • 152 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2021, up from 149 in Q4 2020.
  • Funds reported $493M of Rigel Pharmaceuticals stock for Q1 2021, up 0.71% quarter-over-quarter.
  • 28 funds opened new Rigel Pharmaceuticals positions in Q1 2021 and 23 closed out, a net change of +5 holders.
  • The largest Rigel Pharmaceuticals buyer in Q1 2021 was Lord, Abbett & Co, an estimated $19.2M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2021 was Wellington Management Group, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2021.